Literature DB >> 26465790

Role of Vitamin D in Hospitalized Children With Lower Tract Acute Respiratory Infections.

Miriam Cebey-López1, Jacobo Pardo-Seco, Alberto Gómez-Carballa, Nazareth Martinón-Torres, Irene Rivero-Calle, Antonio Justicia, Lorenzo Redondo, José María Martinón-Sánchez, María Del Carmen Martínez-Padilla, Francisco Giménez-Sánchez, Antonio Salas, Federico Martinón-Torres.   

Abstract

BACKGROUND: Vitamin D is known to have modulatory actions in the immune system. Its influence on the severity of lower tract acute respiratory infections (LT-ARIs) is unclear.
OBJECTIVES: The aim of the present study was to evaluate the role of vitamin D on LT-ARI in paediatric patients.
METHODS: Children admitted to hospital with LT-ARI were prospectively recruited through the GENDRES network (March 2009-May 2013). The 25-hydroxyvitamin D (25-OHD) levels were measured by immunoassay. The severity of the illness was evaluated according to clinical scales, length of hospital stay, ventilatory requirements, and pediatric intensive care unit admission.
RESULTS: A total of 347 patients with a median (interquartile range) age of 8.4 (2.6-21.1) months were included. The mean (SD) 25-OHD levels in our series were 27.1 (11.3) ng/mL. In this study, a cutoff value of ≥30 ng/mL was considered optimal vitamin status. Patients with 25-OHD levels <20 ng/mL were at a higher risk of showing severe signs of respiratory difficulties (OR 5.065, 95% confidence interval 1.998-12.842; P = 0.001) than patients with normal values, and had a 117% higher risk of oxygen necessity and 217% higher risk of ventilatory requirement than those patients with normal values. An inverse correlation was found between 25-OHD levels and the severity in the evaluated scales. 25-OHD levels did not influence PICU admission rate or length of hospital stay.
CONCLUSIONS: 25-OHD levels of children admitted because of a LT-ARI are <30 ng/mL. Lower levels of 25-OHD were found to be correlated with severity of the disease. The possible role of abnormal 25-OHD levels as a facilitator or consequence of the infection needs further evaluation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26465790     DOI: 10.1097/MPG.0000000000001003

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

1.  Vitamin D levels in a pediatric population of a primary care centre: a public health problem?

Authors:  J M Fernández Bustillo; A Fernández Pombo; R Gómez Bahamonde; E Sanmartín López; O Gualillo
Journal:  BMC Res Notes       Date:  2018-11-08

2.  Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis.

Authors:  Margarita Cariolou; Meghan A Cupp; Evangelos Evangelou; Ioanna Tzoulaki; Antonio J Berlanga-Taylor
Journal:  BMJ Open       Date:  2019-05-22       Impact factor: 2.692

3.  Effect of maternal vitamin D supplementation on nasal pneumococcal acquisition, carriage dynamics and carriage density in infants in Dhaka, Bangladesh.

Authors:  Shaun K Morris; Daniel E Roth; Mahgol Taghivand; Lisa G Pell; Mohammed Z Rahman; Abdullah A Mahmud; Eric O Ohuma; Eleanor M Pullangyeum; Tahmeed Ahmed; Davidson H Hamer; Stanley H Zlotkin; Jonathan B Gubbay
Journal:  BMC Infect Dis       Date:  2022-01-13       Impact factor: 3.090

Review 4.  The Role of Vitamin D in COVID-19 and the Impact of Pandemic Restrictions on Vitamin D Blood Content.

Authors:  Agata Tomaszewska; Agnieszka Rustecka; Agnieszka Lipińska-Opałka; Rafal P Piprek; Małgorzata Kloc; Bolesław Kalicki; Jacek Z Kubiak
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

5.  Whole Exome Sequencing Identifies New Host Genomic Susceptibility Factors in Empyema Caused by Streptococcus pneumoniae in Children: A Pilot Study.

Authors:  Antonio Salas; Jacobo Pardo-Seco; Ruth Barral-Arca; Miriam Cebey-López; Alberto Gómez-Carballa; Irene Rivero-Calle; Sara Pischedda; María-José Currás-Tuala; Jorge Amigo; José Gómez-Rial; Federico Martinón-Torres
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.